EGFR and lung adenocarcinoma: To address these questions, we conducted a comprehensive study in a large cohort of Chinese patients with lung adenocarcinoma and determined the associations between 5 common driver genes (EGFR, KRAS, ALK, RET, BRAF) and pathological subtypes, as well as their combined impact on prognosis.